Although further studies are needed to explore the mechanisms behind cisplatin nephrotoxicity and the role of KIM-1 in this setting, this novel biomarker is showing promise in early diagnosis and prognosis of AKI. This evidence concerns the gene HAVCR1 and acute kidney injury.